|
Orthologous residues
|
|
Bcl‑2 (human): S70‑p, Bcl‑2 (mouse): S70‑p, Bcl‑2 (rat): S70‑p
|
|
Characterization
|
|
Methods used to characterize site in vivo:
[32P] bio-synthetic labeling, mutation of modification site
|
|
Relevant cell lines - cell types - tissues:
NCI-H1299 (pulmonary), NCI-H69 (pulmonary), NCI-H82 (pulmonary)
|
|
Cellular systems studied:
cell lines
|
|
Species studied:
human
|
|
Upstream Regulation
|
|
Treatments, proteins and their effect on site modification:
|
|
Treatments
|
Referenced Treatments
|
Manipulated Protein
|
Referenced Protein
|
Effect
|
Notes
|
|
staurosporine
|
|
|
|
decrease
|
|
|
PD98059
|
|
|
|
decrease
|
|
|
|
Downstream Regulation
|
|
Effect of modification (process):
apoptosis, inhibited, cell growth, altered
|